Table of Contents

company-logo

Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; Dovitinib, a pan- tyrosine kinase inhibitor for the treatment of renal cell carcinoma; IXEMPRA, a microtubule inhibitor for the treatment of metastatic breast cancer; LiPlaCis, a liposomal formulation of cisplatin, which is in Phase 2 clinical trials for metastatic breast cancer; and 2X-111, a liposomal formulation of doxorubicin that is in Phase 2 clinical trials for metastatic breast cancer and glioblastoma multiforme. The company was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.

Allarity Therapeutics Dividend Announcement

• Allarity Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Allarity Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Allarity Therapeutics Dividend History

Allarity Therapeutics Dividend Yield

Allarity Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Allarity Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Allarity Therapeutics Financial Ratios

P/E ratio-1.62
PEG ratio0.22
P/B ratio1.04
ROE-704.78%
Payout ratio-1.79%
Current ratio2.01
Quick ratio2.01
Cash Ratio1.81

Allarity Therapeutics Dividend FAQ

Does Allarity Therapeutics stock pay dividends?
Allarity Therapeutics does not currently pay dividends to its shareholders.
Has Allarity Therapeutics ever paid a dividend?
No, Allarity Therapeutics has no a history of paying dividends to its shareholders. Allarity Therapeutics is not known for its dividend payments.
Why doesn't Allarity Therapeutics pay dividends?
There are several potential reasons why Allarity Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Allarity Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Allarity Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Allarity Therapeutics a dividend aristocrat?
Allarity Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Allarity Therapeutics a dividend king?
Allarity Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Allarity Therapeutics a dividend stock?
No, Allarity Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Allarity Therapeutics stocks?
To buy Allarity Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Allarity Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.